Early detection of oral potentially malignant disorders (OPMD) and oral squamous cell carcinoma (OSCC) can improve patient prognosis. Biopsy remains the reference standard for diagnosing OPMDs and OSCC, but advances in diagnostic technologies and living guideline methodologies have created a need for updated guidance on early cancer detection. Developed in collaboration with the Center for Integrative Global Oral Health at the University of Pennsylvania School of Dental Medicine (Penn Dental Medicine), this first of a multi-part series exploring cancer detection methods provides recommendations on when cytology adjuncts may be appropriate.
Part two through four of the series will examine vital staining, light-based adjuncts, and salivary tests, respectively, to be published throughout 2026.
For questions or comments about the living guideline, please contact livingguidelineprogram@ada.org.
Please note: the infographic below may take a moment to load.
